cendakimab: Clinical Trials

2 trials of cendakimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow cendakimab: new trials by email Literature Review of cendakimab trials Research Report on cendakimab

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis
CC-93538, Placebo - Dermatitis, Atopic, Eczema
Phase 2CompletedCelgene2212021-05-142024-01-03
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
RPC4046, Placebo - Eosinophilic Esophagitis
Phase 2CompletedCelgene1002014-08-312017-05-09

Conditions studied

Dermatitis, Atopic (1)  ·  Eczema (1)  ·  Eosinophilic Esophagitis (1)

Sponsors

Celgene (2)

Countries

Canada (2)  ·  United States (2)  ·  China (1)  ·  Czechia (1)  ·  Japan (1)  ·  Poland (1)  ·  Switzerland (1)

Results publications

PMID 30395812, PMID 32205221, PMID 39018038, PMID 41067281